采用ASiR-V联合SmartmA重建的超低剂量CT与低剂量CT在肺结节检出及Lung-RADS分类中的对比
研究纳入210例肺癌筛查患者,先行常规胸部低剂量CT(0.80±0.28 mSv),随后立即行超低剂量CT(0.16±0.03 mSv),后者采用120 kV/SmartmA(噪声指数28 HU)扫描并以ASiR-V70%重建。以低剂量CT为参考标准,超低剂量CT检出结节的总体敏感度为90.1%,对长径≥6 mm实性结节及长径≥6 mm且衰减值≥-700 HU的纯磨玻璃结节敏感度均达100%,两种扫描的Lung-RADS分类一致性良好。作者结论认为,该超低剂量CT方案适用于BMI≤35 kg/m²人群的肺癌筛查。
要点
- 超低剂量CT(0.16 mSv)检出肺结节总体敏感度90.1%,对长径≥6 mm实性结节敏感度100%。
- 长径≥6 mm的纯磨玻璃结节中,衰减值≥-700 HU者超低剂量CT敏感度100%。
- 超低剂量CT与低剂量CT的Lung-RADS分类一致性良好。
关键影像表现/征象
- 低剂量CT共显示362个结节,超低剂量CT检出结节的总体敏感度为90.1%。
- 超低剂量CT对长径≥1 mm实性结节的敏感度为96.6%(228/236),对长径≥6 mm实性结节的敏感度为100%(26/26)。
- 超低剂量CT对长径≥6 mm纯磨玻璃结节的总体敏感度为93%(40/43),对其中衰减值≥-700 HU者的敏感度为100%(29/29)。
- 两种扫描的Lung-RADS分类一致性良好。
诊断标准与关键数值
- 以低剂量CT为参考标准,超低剂量CT检出结节的总体敏感度为90.1%。
- 超低剂量CT对长径≥1 mm实性结节的敏感度为96.6%(228/236),对长径≥6 mm实性结节的敏感度为100%(26/26)。
- 超低剂量CT对长径≥6 mm纯磨玻璃结节的总体敏感度为93%(40/43),对其中衰减值≥-700 HU者的敏感度为100%(29/29)。
- 逻辑回归显示,长径是实性结节检出敏感度的唯一独立预测因素(p<0.05);长径和衰减值是纯磨玻璃结节检出敏感度的预测因素(p<0.05)。
临床应用与阅片要点
- 采用ASiR-V联合SmartmA的超低剂量CT方案(0.16 mSv)可用于BMI≤35 kg/m²人群的肺癌筛查,结节检出敏感度高且Lung-RADS分类与低剂量CT一致性良好。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the accuracy of ultra-low-dose computed tomography (ULDCT) with ASiR-V using a noise index (SmartmA) for pulmonary nodule detection and Lung CT Screening Reporting And Data System (Lung-RADS) classifications compared with low-dose CT (LDCT).
MATERIALS AND METHODS: Two-hundred and ten patients referred for lung cancer screening underwent conventional chest LDCT (0.80 ± 0.28 mSv) followed immediately by ULDCT (0.16 ± 0.03 mSv). ULDCT was scanned using 120 kV/SmartmA with a noise index of 28 HU and reconstructed with ASiR-V70%. The types and diameters of all nodules were recorded. The attenuation of pure ground-glass nodules (pGGNs) was measured on LDCT. All nodules were further classified using Lung-RADS. Sensitivities of nodule detection on ULDCT were analysed using LDCT as the reference standard. Logistic regression was used to establish a prediction model for the sensitivity of nodules.
RESULTS: LDCT revealed 362 nodules and the overall sensitivity on ULDCT was 90.1%. The sensitivity for solid nodules (SNs) of ≥1 mm diameter was 96.6% (228/236) and 100% (26/26) for SNs of ≥6 mm diameter. For pGGNs of ≥6 mm, the overall sensitivity was 93% (40/43) and 100% (29/29) for nodules with a attenuation value -700 HU or more. The agreement of Lung-RADS classification between two scans was good. On logistic regression, diameter was the only independent predictor for sensitivity of SNs (p<0.05). Diameter and attenuation value were predictors for pGGNs (p<0.05).
CONCLUSION: ULDCT with ASiR-V using SmartmA is suitable for lung-cancer screening in people with a BMI ≤35 kg/m2 as it has a low radiation dose of 0.16 mSv, high sensitivity for nodule detection and good performance of Lung-RADS classifications.
引用
- Ye K, Chen M, Li J, et al. Ultra-low-dose CT reconstructed with ASiR-V using SmartmA for pulmonary nodule detection and Lung-RADS classifications compared with low-dose CT. Clin Radiol. 2020. PMID: 33293025. doi:10.1016/j.crad.2020.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。